Related Experiment Video

Updated: Mar 27, 2026

In Vitro Analysis of E3 Ubiquitin Ligase Function
06:06

In Vitro Analysis of E3 Ubiquitin Ligase Function

Published on: May 14, 2021

6.2K

Diabetic cardiomyopathy: role of the E3 ubiquitin ligase

Tao Bai1, Fan Wang2, Nicholas Mellen3

  • 1Cardiovascular Center, First Hospital of Jilin University, Changchun, China; Kosair Children's Hospital Research Institute, Departments of Pediatrics and Radiation Oncology, University of Louisville, Louisville, Kentucky.

American Journal of Physiology. Endocrinology and Metabolism
|January 7, 2016
PubMed

Insights

E3 ubiquitin ligases (E3s) are key drivers of diabetic cardiomyopathy (DCM), a serious diabetes complication. Understanding E3 roles offers new strategies for protecting the heart from diabetes.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cardiology

Background:

  • Diabetic cardiomyopathy (DCM) is a major cause of mortality in diabetes patients.
  • DCM involves cardiac hypertrophy, apoptosis, fibrosis, and altered insulin metabolism.
  • E3 ubiquitin ligases (E3s) are crucial components of the ubiquitin-proteasome system.

Purpose of the Study:

  • To review the roles of E3 ubiquitin ligases in the pathogenesis of diabetic cardiomyopathy.
  • To enhance understanding of DCM development mechanisms.
  • To identify novel strategies for protecting the heart in diabetic patients.

Main Methods:

  • Literature review of studies on E3 ubiquitin ligases and DCM.
  • Analysis of E3 roles in cardiac hypertrophy, apoptosis, fibrosis, and insulin metabolism.
  • Examination of E3 modulation of transcription factors and insulin signaling.

Main Results:

  • E3s play vital roles in all key features of DCM.
  • E3s influence transcription factors involved in DCM pathogenesis.
  • E3s degrade insulin receptors and regulate insulin gene transcription, contributing to insulin resistance.

Conclusions:

  • E3 ubiquitin ligases are potential driving forces behind diabetic cardiomyopathy.
  • Targeting E3s may offer a novel therapeutic strategy for DCM.
  • Further research into E3s can lead to improved cardiac protection in diabetes.

Keywords:
E3 ubiquitin ligasediabetesdiabetic cardiomyopathyetiologyventricular remodeling

More Related Videos

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model05:58

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model

Published on: April 18, 2025

723
Evaluation of Substrate Ubiquitylation by E3 Ubiquitin-ligase in Mammalian Cell Lysates09:47

Evaluation of Substrate Ubiquitylation by E3 Ubiquitin-ligase in Mammalian Cell Lysates

Published on: May 10, 2022

3.2K

Related Concept Videos

Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
9.2K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
687
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
3.0K
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
5.5K
The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
2.0K
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
10.5K